BGC > Produktsuche > Seletalisib | 1362850-20-1

Molecular Formula: C23H14ClF3N6O
Molecular Weight: 482.8450696

Description:
Seletalisib is a selective Phosphatidylinositol 3 kinase delta inhibitor originated by UCB. It is an immunomodulator. Phaes I clinical trials for Plaque psoriasis, phaes II clinical trials for Sjogren's syndrome and phaes III clinical trials for Immunodeficiency disorders is on-going.

• Molecular Weight:482.85
• Purity:98%

Molecular Formula:
C23H14ClF3N6O
Canonical SMILES:
C1=CC2=CC(=C(N=C2C(=C1)Cl)C3=C[N+](=CC=C3)[O-])C(C(F)(F)F)NC4=NC=NC5=C4N=CC=C5
InChI:
InChI=1S/C23H14ClF3N6O/c24-16-6-1-4-13-10-15(18(31-19(13)16)14-5-3-9-33(34)11-14)21(23(25,26)27)32-22-20-17(29-12-30-22)7-2-8-28-20/h1-12,21H,(H,29,30,32)/t21-/m1/s1
InChIKey:
LNLJHGXOFYUARS-OAQYLSRUSA-N
Solubility:
Soluble in DMSO
Appearance:
Powder
Storage: -20°C Freezer
Synonyms:
UCB-5857; UCB 5857; UCB5857; (R)-3-(8-chloro-3-(2,2,2-trifluoro-1-(pyrido[3,2-d]pyrimidin-4-ylamino)ethyl)quinolin-2-yl)pyridine 1-oxide